How to Use the USP–NF Errata Table

Change
Buffer, Diluent, Mobile phase, System suitability, and Chromatographic system: Proceed as directed in the Assay.

to:
Buffer, Mobile phase, System suitability, and Chromatographic system: Proceed as directed in the Assay.

Line 1 of Standard solution: Change
1.0 µg/mL of USP Itraconazole RS in Diluent
to:
10.0 µg/mL of USP Itraconazole RS in Diluent

Line 1 of B. Thin-Layer Chromatographic Identification Test <201>: Change
The R_F value of the
principal spot from Sample solution A corresponds to that from Standard solution A, as
described in the test for Organic Impurities.
to:
The R_F value of the
principal spot from Sample solution B corresponds to that from Standard solution A, as
described in the test for Organic Impurities.

Line 2 of Analysis: Change

Samples: Acid stage standard solution, Buffer stage
standard solution, Acid stage sample solutions, and
Buffer stage sample solutions
to:

Samples: Acid stage standard solution, Buffer stage
standard solution, and Sample solutions

Line 1 of Sample solution: Change

Transfer a portion of the powdered pellets, from the Capsule content, equivalent to 80–90 mg of
esomeprazole, to a 200-mL volumetric flask, add 20 mL of methanol, and shake for 30 s.

to:

Transfer a portion of the powdered pellets (about 80–90 mg), from the Capsule content, to a 200-mL volumetric flask, add 20 mL of methanol, and shake for 30 s.

Line 11 of Analysis: Change
C_U = concentration of olanzapine in the Sample solution (mg/mL)
to:
C_U = nominal concentration of olanzapine in the Sample solution (mg/mL)

Line 5: At end of USP Reference Standards, add
USP Meprobamate RS

Line 5 of Chromatographic system: Change
Column: 4.0-mm x 25-cm; 5-µm packing L##¹
to:
Column: 4.0-mm x 25-cm; 5-µm packing L76
AND
Delete corresponding footnote: Available as Metrosep C4-250.

Line 1 of Buffer: Change
3.5 g/mL
to:
3.5 g/L

Rows 11 and 15 of Column 2 of Table 2: Change
100
to:
10
AND
Rows 11 and 15 of Column 3 of Table 2: Change
10
to:
1.0
AND
Row 11 of Column 4 of Table 2: Change
1.5
to:
0.15
AND
Row 15 of Column 4 of Table 2: Change
30
to:
3.0

Row 13 of Column 4 of Table 2: Change
25
to:
1.0

Line 2 of Target Elements: Change
Pd
to:
Pb

Line 5 of Analysis: Change
Result = (r_U/r_S) × (C_S/C_U) × P × F × 100
to:
Result = (r_U/r_S) × (C_S/C_U) × P × 100

Line 1 of Column: Change
4.6-mm x 7.5-cm; 3-µm packing L7
to:
4.6-mm x 7.5-cm; 3- or 3.5-µm packing L7

Line 3 of Analysis: Change
0.5 N alcoholic potassium hydroxide
to:
0.5 N alcoholic potassium hydroxide VS

Line 6 of Analysis: Change
0.5 N hydrochloric acid

to:
0.5 N hydrochloric acid VS

Line 4 of Chromatographic system: Delete
The flow rate is about 0.5 mL per minute.

Line 1 of Procedure: Change
Inject a volume (about 0.5 µL)
to:
Inject a volume (about 2.0 µL)

Line 2: Change text of Sample solution from
10.0 mg/mL
to:
10.0 mg/mL of ampicillin

Line 14 of Analysis: Change
W = Sample weight (mg)
to:
W = Sample weight (mg) in 20.0 mL of the Sample solution

In line 14 of Analysis: Change
W = Sample weight (mg)
to:
W = Sample weight (mg) in 20.0 mL of the Sample solution

Line 1 of Aqueous potassium hydroxide solution: Change
Dissolve 800 mg of potassium hydroxide in 1000 mL of freshly boiled water, mix, and cool.
to:
Dissolve 800 g of potassium hydroxide in 1000 mL of freshly boiled water, mix, and cool.